AT356812B - Verfahren zur herstellung einer stabilen lyophilisierbaren bzw. lyophilisierten erythro- zyten-praeparation - Google Patents

Verfahren zur herstellung einer stabilen lyophilisierbaren bzw. lyophilisierten erythro- zyten-praeparation

Info

Publication number
AT356812B
AT356812B AT843476A AT843476A AT356812B AT 356812 B AT356812 B AT 356812B AT 843476 A AT843476 A AT 843476A AT 843476 A AT843476 A AT 843476A AT 356812 B AT356812 B AT 356812B
Authority
AT
Austria
Prior art keywords
lyophilizable
lyophilized
stable
producing
erythrocyte preparation
Prior art date
Application number
AT843476A
Other languages
English (en)
Other versions
ATA843476A (de
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Priority to AT83979A priority Critical patent/AT364091B/de
Publication of ATA843476A publication Critical patent/ATA843476A/de
Application granted granted Critical
Publication of AT356812B publication Critical patent/AT356812B/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/554—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
    • G01N33/555—Red blood cell
    • G01N33/556—Fixed or stabilised red blood cell
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0221—Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/18—Erythrocytes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT843476A 1975-11-14 1976-11-12 Verfahren zur herstellung einer stabilen lyophilisierbaren bzw. lyophilisierten erythro- zyten-praeparation AT356812B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT83979A AT364091B (de) 1975-11-14 1979-02-05 Durchfuehrung eines haemagglutinationstests

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752551208 DE2551208C3 (de) 1975-11-14 1975-11-14 Verfahren zur Herstellung einer stabilen Erythrozyten-Präparation

Publications (2)

Publication Number Publication Date
ATA843476A ATA843476A (de) 1979-10-15
AT356812B true AT356812B (de) 1980-05-27

Family

ID=5961771

Family Applications (1)

Application Number Title Priority Date Filing Date
AT843476A AT356812B (de) 1975-11-14 1976-11-12 Verfahren zur herstellung einer stabilen lyophilisierbaren bzw. lyophilisierten erythro- zyten-praeparation

Country Status (18)

Country Link
JP (1) JPS5261218A (de)
AR (1) AR213420A1 (de)
AT (1) AT356812B (de)
AU (1) AU511427B2 (de)
BE (1) BE848377A (de)
BR (1) BR7607564A (de)
CH (1) CH626999A5 (de)
DE (1) DE2551208C3 (de)
DK (1) DK146138C (de)
ES (1) ES453136A1 (de)
FR (1) FR2331352A1 (de)
GB (1) GB1563839A (de)
IE (1) IE44471B1 (de)
IT (1) IT1063992B (de)
LU (1) LU76194A1 (de)
MX (1) MX3937E (de)
NL (1) NL189133C (de)
SE (1) SE431800B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4302355A (en) * 1977-08-01 1981-11-24 Warner-Lambert Company Platelet reference control
DE2828820A1 (de) * 1977-08-01 1979-02-08 Warner Lambert Co Verfahren zur herstellung einer stabilen blutplaettchensuspension und nach dem verfahren erhaltene stabile blutplaettchensuspension
JPS5917388B2 (ja) * 1979-02-22 1984-04-20 富士レビオ株式会社 間接凝集反応用吸収剤
EP0039195B1 (de) * 1980-04-28 1986-06-18 Montefiore Hospital and Medical Center Verfahren zur Feststellung von Antikörpern
GB2138132B (en) * 1983-04-12 1987-02-18 Robin Royston Amos Coombs Storage-stable antibody-linked erythrocytes
JPS6161055A (ja) * 1984-08-31 1986-03-28 Shionogi & Co Ltd ウイルス赤血球凝集反応試験用鳥類固定赤血球の保存液
DE3501496A1 (de) * 1985-01-18 1986-07-24 Behringwerke Ag, 3550 Marburg Verfahren zur bestimmung der aktivitaet des komplementsystems des blutes
FR2617185B1 (fr) * 1987-06-25 1990-03-09 Fondation Nale Transfusion San Procede de stabilisation de membranes cellulaires et son app lication a la conservation des cellules sous une forme protegeant l'essentiel de leurs antigenes de surface
US5079173A (en) * 1987-08-19 1992-01-07 Shionogi & Co., Ltd. Methods, hybridomas, monoclonal antibodies and sensitized cells for measuring hbs antigen
JPH01107154A (ja) * 1987-10-20 1989-04-25 Seitetsu Kagaku Co Ltd 加工赤血球およびその製造方法
US5045446A (en) * 1988-08-26 1991-09-03 Cryopharm Corporation Lyophilization of cells
IL90188A0 (en) * 1988-05-18 1989-12-15 Cryopharm Corp Process and medium for the lyophilization of erythrocytes
EP0356258A3 (de) * 1988-08-26 1990-06-06 Cryopharm Corporation Gefriertrocknungsmethode für rote Blutkörperchen und Mittel dafür
US5059518A (en) * 1988-10-20 1991-10-22 Coulter Corporation Stabilized lyophilized mammalian cells and method of making same
US5882649A (en) * 1990-04-24 1999-03-16 Flustat Pty. Ltd. Oral vaccine comprising antigen surface-associated with red blood cells
ATE162402T1 (de) * 1990-04-24 1998-02-15 Flustat Pty Ltd Oraler an der oberfläche von erythrozyten gebundene antigene beinhaltender impfstoff
JPH09503051A (ja) * 1993-07-05 1997-03-25 ノーザン ジェネラル ホスピタル エヌ．エイチ．エス．トラスト 細胞の調製および安定化
CN1126437A (zh) * 1993-07-05 1996-07-10 北方总医院N.H.S.托拉斯 细胞的制备和稳定化
CA2187196A1 (en) * 1994-04-05 1995-10-12 Northern General Hospital N.H.S. Trust Preparation and stabilisation of cell suspensions
GB2313288B (en) * 1996-05-24 2000-07-12 North Gen Hospital Nhs Trust Specimen collection fluid
CN100376669C (zh) 2005-02-25 2008-03-26 深圳迈瑞生物医疗电子股份有限公司 生物红细胞体积长期稳定的处理方法
CN111295094A (zh) 2017-10-09 2020-06-16 泰尔茂比司特生物技术有限公司 冻干容器及使用冻干容器的方法
KR20200136412A (ko) * 2018-03-27 2020-12-07 이그잭트 사이언시즈 코포레이션 헤모글로빈 안정화 방법 및 동일한 수행을 위한 시약
CA3130700A1 (en) 2019-03-14 2020-09-17 Terumo Bct Biotechnologies, Llc Lyophilization container fill fixture, system and method of use
FR3121577B1 (fr) 2021-04-12 2024-03-08 Elitech Microbio Composition stabilisante, procédé utilisant ladite composition pour la fabrication de produits de contrôle d’analyses de prélèvements biologiques chez les mammifères, et produits de contrôle issus de la mise en œuvre dudit procédé
CN115399314B (zh) * 2022-11-01 2023-05-19 天津德祥生物技术股份有限公司 一种能冻干保存的人abo血型反定型红细胞及保存方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1521350A (fr) * 1965-09-10 1968-04-19 Princeton Lab Détection de la mononucléose
DE2025718C3 (de) * 1967-11-13 1979-06-13 Abbott Laboratories, Chicago, Ill. (V.St.A.) Verfahren zum Stabilisieren von lyophillsierten Erythrozyten
GB1244344A (en) * 1967-11-13 1971-08-25 Abbott Lab Hemagglutination testing procedure employing stabilized and potentiated erythrocytes and a method for their preparation
FR2233024A1 (en) * 1973-06-15 1975-01-10 Greyward Lab Interconti Treponema haemagglutination test - using tanned avian erythrocytes as carrier for ireponema antigen

Also Published As

Publication number Publication date
IE44471L (en) 1977-05-14
ES453136A1 (es) 1978-01-16
BE848377A (fr) 1977-05-16
FR2331352A1 (fr) 1977-06-10
SE7612622L (sv) 1977-05-15
NL7612439A (nl) 1977-05-17
NL189133B (nl) 1992-08-17
DK146138C (da) 1983-11-28
IE44471B1 (en) 1981-12-16
JPS5261218A (en) 1977-05-20
BR7607564A (pt) 1977-09-27
GB1563839A (en) 1980-04-02
JPS616941B2 (de) 1986-03-03
IT1063992B (it) 1985-02-18
AU1958876A (en) 1978-05-18
AR213420A1 (es) 1979-01-31
DK510976A (da) 1977-05-15
AU511427B2 (en) 1980-08-21
DE2551208A1 (de) 1977-05-26
CH626999A5 (en) 1981-12-15
MX3937E (es) 1981-10-02
DK146138B (da) 1983-07-04
DE2551208C3 (de) 1981-05-27
ATA843476A (de) 1979-10-15
FR2331352B1 (de) 1982-07-09
NL189133C (nl) 1993-01-18
SE431800B (sv) 1984-02-27
DE2551208B2 (de) 1980-09-11
LU76194A1 (de) 1977-06-06

Similar Documents

Publication Publication Date Title
AT356812B (de) Verfahren zur herstellung einer stabilen lyophilisierbaren bzw. lyophilisierten erythro- zyten-praeparation
AT348544B (de) Verfahren zur herstellung von n-phosphono- methylglycin
AT358002B (de) Verfahren zur herstellung von methacrolein
AT351532B (de) Verfahren zur herstellung von 6a,10a-trans-1- hydroxy-3-substituierten-6,6-dimethyl-6,6a,7,8, 10,10a-hexahydro-9h-dibenzo(b,d)-pyran-9-onen
AT355041B (de) Verfahren zur herstellung neuer n,n'-thio-bis- oximcarbamate
AT369987B (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung
AT373885B (de) Verfahren zur herstellung von 1,2,3-thiadiazol -5-yl-harnstoffen
AT349477B (de) Verfahren zur herstellung von feinteiligem, festem cyanurchlorid
AT348545B (de) Verfahren zur herstellung von 1-aminoalkan-1,1- diphosphonsaeuren
AT345780B (de) Verfahren zur herstellung von neuem 3,7- dimethyl-3-hydroxyoctannitril
AT367773B (de) Verfahren zur herstellung von 25,26-dihydroxycholesterin
AT356815B (de) Verfahren zur herstellung von 3',4'-dideoxy- kanamycin b
AT353268B (de) Verfahren zur herstellung von 6a,10a-cis- hexahydrodibenzopyranonen
AT358055B (de) Verfahren zur herstellung von 2-chlor-4,6-bis- -alkylamino-s-triazinen
DD132496A5 (de) Verfahren zur kontinuierlichen herstellung von 2,5-dioxo-1-oxa-2-phospholanen
AT353759B (de) Verfahren zur herstellung von 1,2-dichloraethan
AT363887B (de) Verfahren zur herstellung von 2,5-diketogluconsaeure
AT356303B (de) Verfahren zur herstellung von 9,11-halo- genierten steroiden
AT373872B (de) Verfahren zur herstellung von 2,2-dialkyl-4-methyl-5,5-dialkyl-3-formyl-3-pyr olinen
AT368139B (de) Verfahren zur herstellung von 2-alkoxy-4,6-dichlor-s-triazinen
AT356657B (de) Verfahren zur herstellung von 2,6-methano-3- -benzazocinen
AT363453B (de) Verfahren zur herstellung von ammoniumalkanoaten
AT371805B (de) Verfahren zur herstellung von n-dialkylaminomethyl-s,s-diarylsulfoximiden
ATA16676A (de) Verfahren zur herstellung von n-phosphonomethylglycin
ATA568178A (de) Verfahren zur herstellung von 2,4-diamino-5- -benzylpyrimidinen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee